Corey R. Hopkins, Ph.D.

Affiliations: 
2002 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Chemical Biology
Google:
"Corey Hopkins"
Mean distance: 9.05
 
SNBCP

Parents

Sign in to add mentor
Peter Wipf grad student 2002 University of Pittsburgh
 (Studies toward the total synthesis of naphthyridinomycin/bioxalomycin antitumor antibiotics.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Anderson A, Vo BN, Marron Fernandez de Velasco E, et al. (2021) . Molecular Pharmacology
Sharma S, Lesiak L, Aretz CD, et al. (2021) Discovery, synthesis and biological characterization of a series of -(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators. Rsc Medicinal Chemistry. 12: 1366-1373
Vo BN, Marron Fernandez de Velasco E, Rose TR, et al. (2021) Bidirectional influence of limbic GIRK channel activation on innate avoidance behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Kumar B, Ahmad R, Sharma S, et al. (2021) PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells. Cancers. 13
Vadukoot AK, Sharma S, Aretz CD, et al. (2020) Synthesis and SAR Studies of 1-Pyrrolo[2,3-]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors. Acs Medicinal Chemistry Letters. 11: 1848-1854
Engers DW, Bollinger SR, Felts AS, et al. (2020) Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 30: 127418
Burkovetskaya ME, Liu Q, Vadukoot AK, et al. (2020) KVA-D-88, a novel preferable phosphodiesterase 4B inhibitor, decreases cocaine-mediated reward properties in vivo. Acs Chemical Neuroscience
Antonio-Tolentino K, Hopkins CR. (2020) Selective α7 nicotinic receptor agonists and positive allosteric modulators for the treatment of schizophrenia - a review. Expert Opinion On Investigational Drugs. 1-7
Belot A, Gourbeyre O, Fay A, et al. (2019) LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA. Haematologica
Aretz CD, Vadukoot AK, Hopkins CR. (2019) Discovery of Small Molecule Renal Outer Medullary Potassium (ROMK) Channel Inhibitors: A Brief History of Medicinal Chemistry Approaches To Develop Novel Diuretic Therapeutics. Journal of Medicinal Chemistry
See more...